Connection

MIGUEL A RODRIGUEZ-BIGAS to Colorectal Neoplasms, Hereditary Nonpolyposis

This is a "connection" page, showing publications MIGUEL A RODRIGUEZ-BIGAS has written about Colorectal Neoplasms, Hereditary Nonpolyposis.
  1. Surgical treatment of hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome). Fam Cancer. 2013 Jun; 12(2):295-300.
    View in: PubMed
    Score: 0.324
  2. Role of surgery in familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer (Lynch syndrome). Surg Oncol Clin N Am. 2009 Oct; 18(4):705-15.
    View in: PubMed
    Score: 0.251
  3. Lynch syndrome: implications for the surgeon. Clin Colorectal Cancer. 2003 Aug; 3(2):92-8.
    View in: PubMed
    Score: 0.164
  4. Rectal cancer in hereditary nonpolyposis colorectal cancer. Am J Surg. 2001 Mar; 181(3):207-10.
    View in: PubMed
    Score: 0.139
  5. Energy balance related lifestyle factors and risk of endometrial and colorectal cancer among individuals with lynch syndrome: a systematic review. Fam Cancer. 2019 10; 18(4):399-420.
    View in: PubMed
    Score: 0.123
  6. Universal screening for Lynch syndrome in a large consecutive cohort of Chinese colorectal cancer patients: High prevalence and unique molecular features. Int J Cancer. 2019 05 01; 144(9):2161-2168.
    View in: PubMed
    Score: 0.119
  7. Cancer genetics and insurance. Am J Hum Genet. 1999 Jan; 64(1):328-9.
    View in: PubMed
    Score: 0.119
  8. Characteristics of small bowel carcinoma in hereditary nonpolyposis colorectal carcinoma. International Collaborative Group on HNPCC. Cancer. 1998 Jul 15; 83(2):240-4.
    View in: PubMed
    Score: 0.116
  9. Health, life, and disability insurance and hereditary nonpolyposis colorectal cancer. Am J Hum Genet. 1998 Mar; 62(3):736-7.
    View in: PubMed
    Score: 0.113
  10. Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Biliary Tract Cancers Associated with Lynch Syndrome. J Gastrointest Cancer. 2018 Mar; 49(1):93-96.
    View in: PubMed
    Score: 0.113
  11. A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines. J Natl Cancer Inst. 1997 Dec 03; 89(23):1758-62.
    View in: PubMed
    Score: 0.111
  12. In Silico Systems Biology Analysis of Variants of Uncertain Significance in Lynch Syndrome Supports the Prioritization of Functional Molecular Validation. Cancer Prev Res (Phila). 2017 Oct; 10(10):580-587.
    View in: PubMed
    Score: 0.108
  13. Genetic testing is important in families with a history suggestive of hereditary non-polyposis colorectal cancer even if the Amsterdam criteria are not fulfilled. Br J Surg. 1997 Jul; 84(7):1027-8.
    View in: PubMed
    Score: 0.107
  14. Identification of MSH2 inversion of exons 1-7 in clinical evaluation of families with suspected Lynch syndrome. Fam Cancer. 2017 07; 16(3):357-361.
    View in: PubMed
    Score: 0.107
  15. A comparison between Lynch syndrome and sporadic colorectal cancer survivors' satisfaction with their healthcare providers. Cancer Med. 2017 03; 6(3):698-707.
    View in: PubMed
    Score: 0.105
  16. Colorectal cancer in patients aged 30 years or younger. Surg Oncol. 1996 Aug; 5(4):189-94.
    View in: PubMed
    Score: 0.101
  17. Prophylactic colectomy for gene carriers in hereditary nonpolyposis colorectal cancer. Has the time come? Cancer. 1996 Jul 15; 78(2):199-201.
    View in: PubMed
    Score: 0.101
  18. Establishment of a hereditary nonpolyposis colorectal cancer registry. Dis Colon Rectum. 1996 Jun; 39(6):649-53.
    View in: PubMed
    Score: 0.100
  19. A Prospective Six Sigma Quality Improvement Trial to Optimize Universal Screening for Genetic Syndrome Among Patients With Young-Onset Colorectal Cancer. J Natl Compr Canc Netw. 2015 Jul; 13(7):865-72.
    View in: PubMed
    Score: 0.094
  20. Role of microsatellite instability-low as a diagnostic biomarker of Lynch syndrome in colorectal cancer. Cancer Genet. 2014 Oct-Dec; 207(10-12):495-502.
    View in: PubMed
    Score: 0.089
  21. Evaluating Lynch syndrome in very early onset colorectal cancer probands without apparent polyposis. Fam Cancer. 2010 Jun; 9(2):99-107.
    View in: PubMed
    Score: 0.066
  22. Re: A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda Guidelines. J Natl Cancer Inst. 1998 Jun 17; 90(12):939-40.
    View in: PubMed
    Score: 0.057
  23. Who should be sent for genetic testing in hereditary colorectal cancer syndromes? J Clin Oncol. 2007 Aug 10; 25(23):3534-42.
    View in: PubMed
    Score: 0.054
  24. DNMT3b polymorphism and hereditary nonpolyposis colorectal cancer age of onset. Cancer Epidemiol Biomarkers Prev. 2006 May; 15(5):886-91.
    View in: PubMed
    Score: 0.050
  25. IGF1 gene polymorphism and risk for hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst. 2006 Jan 18; 98(2):139-43.
    View in: PubMed
    Score: 0.049
  26. Surgical implications of colorectal cancer genetics. Surg Oncol Clin N Am. 2006 Jan; 15(1):51-66, vi.
    View in: PubMed
    Score: 0.048
  27. ATM polymorphism and hereditary nonpolyposis colorectal cancer (HNPCC) age of onset (United States). Cancer Causes Control. 2005 Aug; 16(6):749-53.
    View in: PubMed
    Score: 0.047
  28. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst. 2004 Feb 18; 96(4):261-8.
    View in: PubMed
    Score: 0.043
  29. Suspected HNPCC and Amsterdam criteria II: evaluation of mutation detection rate, an international collaborative study. Int J Colorectal Dis. 2002 Mar; 17(2):109-14.
    View in: PubMed
    Score: 0.037
  30. The reliability of immunohistochemistry as a prescreening method for the diagnosis of hereditary nonpolyposis colorectal cancer (HNPCC)--results of an international collaborative study. Fam Cancer. 2001; 1(2):87-92.
    View in: PubMed
    Score: 0.034
  31. Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis. Dis Colon Rectum. 1999 Jun; 42(6):710-5; discussion 715-6.
    View in: PubMed
    Score: 0.031
  32. Clinical implications of multiple colorectal carcinomas in hereditary nonpolyposis colorectal carcinoma. Dis Colon Rectum. 1999 Jun; 42(6):717-21.
    View in: PubMed
    Score: 0.031
  33. Novel hMLH1 and hMSH2 germline mutations in African Americans with colorectal cancer. JAMA. 1999 Jun 23-30; 281(24):2316-20.
    View in: PubMed
    Score: 0.031
  34. Survival of patients with hereditary colorectal cancer: comparison of HNPCC and colorectal cancer in FAP patients with sporadic colorectal cancer. Int J Cancer. 1999 Jan 18; 80(2):183-7.
    View in: PubMed
    Score: 0.030
  35. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer. 1998 Jul 15; 83(2):259-66.
    View in: PubMed
    Score: 0.029
  36. Somatic frameshift mutations in DNA mismatch repair and proapoptosis genes in hereditary nonpolyposis colorectal cancer. Cancer Res. 1998 Mar 01; 58(5):997-1003.
    View in: PubMed
    Score: 0.028
  37. Genomic DNA-based hMSH2 and hMLH1 mutation screening in 32 Eastern United States hereditary nonpolyposis colorectal cancer pedigrees. Cancer Res. 1997 Sep 01; 57(17):3798-803.
    View in: PubMed
    Score: 0.027
  38. Rectal cancer risk in hereditary nonpolyposis colorectal cancer after abdominal colectomy. International Collaborative Group on HNPCC. Ann Surg. 1997 Feb; 225(2):202-7.
    View in: PubMed
    Score: 0.026
  39. High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer. J Clin Oncol. 2015 Nov 01; 33(31):3544-9.
    View in: PubMed
    Score: 0.023
  40. The clinical and genetic manifestations of hereditary nonpolyposis colorectal carcinoma. Am J Surg. 1995 Mar; 169(3):368-72.
    View in: PubMed
    Score: 0.023
  41. Genome-wide allelotyping indicates increased loss of heterozygosity on 9p and 14q in early age of onset colorectal cancer. Cytogenet Cell Genet. 1999; 86(2):142-7.
    View in: PubMed
    Score: 0.007
  42. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998 Nov 15; 58(22):5248-57.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.